MYADM and neoplasm: The results showed that MYADM was weak negatively correlated with TMB (p = 0.014, r = −0.08), but not with MSI (p = 0.256, r = 0.04), TMB has been found in a variety of tumor immunotherapy in recent years as an independent biomarker that can be used to predict the efficacy of immunotherapy.